March 10, 2026 Experience Western Union $450 million notes offering We advised the joint book-running managers on the investment-grade debt offering
March 9, 2026 Experience Abbott Laboratories $20 billion notes offering We advised the joint book-running managers on the offering
March 9, 2026 Experience Mizrahi Tefahot Bank $700 million senior notes offering We advised Mizrahi Tefahot Bank on the offering
March 9, 2026 Experience Mizrahi Tefahot Bank $750 million Tier 2 subordinated notes We advised Mizrahi Tefahot Bank on a Rule 144A / Regulation S Tier 2 subordinated debt offering
March 9, 2026 Experience Oculis Holding $100 million at-the-market offering We advised the sales agent on the offering
March 9, 2026 Experience indie Semiconductor $150 million convertible senior notes offering We advised the representatives of the initial purchasers on the offering
March 9, 2026 Experience BBVA $2.5 billion senior non-preferred notes offering We advised BBVA on its offering of senior non-preferred notes
March 6, 2026 Experience MiniMed $560 million IPO The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
March 6, 2026 Experience Canadian Pacific Railway $1.2 billion notes offering We advised the joint-bookrunning managers on the investment grade offering
March 6, 2026 Experience Schellman strategic investment from Goldman Sachs Alternatives We are advising Lightyear Capital and Schellman on the transaction